The insulin-like growth factor 1 receptor (IGF-1R), the 'master' lifespan regulator, plays a vital role in directly regulating hippocampal hyperactivity in the brain, report scientists. The researchers hope their findings can be used to indicate a new direction for therapy used to treat patients in the early stages of Alzheimer's disease.